Ruijs-Aalfs syndrome
Ruijs-Aalfs syndrome is a rare genetic disorder characterized by early-onset cirrhosis of the liver, hypercholesterolemia (elevated levels of cholesterol in the blood), and often accompanied by developmental delay and intellectual disability. The syndrome is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition.
Causes[edit | edit source]
Ruijs-Aalfs syndrome is caused by mutations in the YY1AP1 gene. This gene plays a crucial role in DNA repair and cell cycle regulation. Mutations in YY1AP1 disrupt these processes, leading to the symptoms observed in the syndrome. The exact mechanism by which these mutations lead to the specific features of the syndrome is still under investigation.
Symptoms[edit | edit source]
The primary symptoms of Ruijs-Aalfs syndrome include:
- Early-onset cirrhosis of the liver, which can lead to liver failure.
- Hypercholesterolemia, which increases the risk of developing cardiovascular diseases.
- Developmental delay and intellectual disability, varying in severity among affected individuals.
Other possible symptoms may include growth retardation, skeletal abnormalities, and distinctive facial features, although these are less commonly reported.
Diagnosis[edit | edit source]
Diagnosis of Ruijs-Aalfs syndrome is based on the clinical presentation of the symptoms, family history, and confirmed through genetic testing. Genetic testing can identify mutations in the YY1AP1 gene, confirming the diagnosis.
Treatment[edit | edit source]
There is no cure for Ruijs-Aalfs syndrome, and treatment is symptomatic and supportive. Management of the condition may include:
- Regular monitoring and management of liver function to address cirrhosis.
- Medications to control cholesterol levels.
- Supportive therapies for developmental delay and intellectual disability, such as special education and physical therapy.
Prognosis[edit | edit source]
The prognosis for individuals with Ruijs-Aalfs syndrome varies depending on the severity of the symptoms and the effectiveness of the management strategies. Early diagnosis and intervention can improve the quality of life for affected individuals.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD